Beijing Tongrentang Co Ltd

Research Beijing Tongrentang Co Ltd (600085.SS) on Bullrun: market cap CNY 34.14B, P/E 38.9, dividend yield 2.1%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is CNY 34.14B; P/E is 38.9; dividend yield is 2.1%.

Peer valuation comparison

Latest P/E is 38.89x versus a Healthcare sector median of 21.8x (78.4% above).

Latest dividend yield is 2.05% versus a Healthcare sector median of 2.4% (14.6% below).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-11-10CNY 34.14B38.92.0%0.5

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.5 CNY, yield 2.1%.

About Beijing Tongrentang Co Ltd

Beijing Tongrentang Co., Ltd engages in the production and sale of traditional Chinese medicine preparations in China and internationally. The company offers various product dosage forms, such as pills, powders, medicated wines, capsules, oral liquids, and drop pills.

ETFs that hold Beijing Tongrentang Co Ltd

US-listed ETFs

Beijing Tongrentang Co Ltd is held by 34 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:

ETFWeightFee
iShares MSCI Emerging Markets ETF (EEM)<0.01%0.72%
iShares Core MSCI Emerging Markets ETF (IEMG)<0.01%0.09%
Vanguard Total International Stock Index Fund ETF Shares (VXUS)<0.01%0.05%
Vanguard FTSE Emerging Markets Index Fund ETF Shares (VWO)<0.01%0.06%
Vanguard Total World Stock Index Fund ETF Shares (VT)<0.01%0.06%
iShares MSCI ACWI ETF (ACWI)<0.01%0.32%
Vanguard FTSE All-World ex-US Index Fund ETF Shares (VEU)<0.01%0.04%
iShares Core MSCI Total International Stock ETF (IXUS)<0.01%0.07%

Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Beijing Tongrentang Co Ltd's market cap?

Beijing Tongrentang Co Ltd's market capitalization is CNY 34.14B.

What is Beijing Tongrentang Co Ltd's P/E ratio?

Beijing Tongrentang Co Ltd's price-to-earnings (P/E) ratio is 38.9.

Does Beijing Tongrentang Co Ltd pay a dividend?

Beijing Tongrentang Co Ltd has a dividend yield of 2.1%.

What does Beijing Tongrentang Co Ltd do?

Beijing Tongrentang Co., Ltd engages in the production and sale of traditional Chinese medicine preparations in China and internationally. The company offers various product dosage forms, such as pills, powders, medicated wines, capsules, oral liquids, and drop pills. Its products are used for cardiovascular, cerebrovascular, gynecology, heat-clearing, respiratory system, nourishing and calming, digestive, pediatrics, wind-dispelling and dampness removing, orthopedics, facial features, dermatological surgery, mental health, and food and beverages applications.